failure to respond or late response
on 01 Oct 2017
Last Applicant/ Owned by
Taboão da Serra
São Paulo
BR
SP,06767-
Serial Number
86966146 filed on 06th Apr 2016
Registration Number
N/A
Correspondent Address
JERALD E. NAGAE, REG. NO. 29,418
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Medicines for human and veterinary use in the treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmolRead More
Medicines for human and veterinary use in the treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; adjuvants for medical purposes; pharmaceutical preparations for human and veterinary use for the treatment and prevention of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; chemical-pharmaceutical preparations for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; nutritional complements in the nature of nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic food, namely, cereals, powdered milk for babies, salt, and sugar adapted for medical use
Commercialization of pharmaceutical products in the nature of products for use in human and veterinary treatment for disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculoskeletal system, and the genitourinary system for the treatment of inflammatory disorders and for use in dermatology, antifungal, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic foods, namely, cereals, powdered milk for babies, salt, and sugar adapted for medical use
No 86966146
No Service Mark
No LULE-2-55166
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 02th Oct 2017 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 01st Oct 2017 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 28th Feb 2017 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 28th Feb 2017 | FINAL REFUSAL E-MAILED |
| 28th Feb 2017 | FINAL REFUSAL WRITTEN |
| 02th Feb 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 01st Feb 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 01st Feb 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 01st Aug 2016 | NON-FINAL ACTION E-MAILED |
| 01st Aug 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
